Earlier, we demonstrated the essential role of Kruppel-like transcription factor, TIEG1, in TGF-β–induced regulatory T cell (Treg) development. In this article, we demonstrate that IL-6, which promotes Th17 development, abrogated TIEG1 nuclear translocation and inhibited TGF-β–induced Treg development. Tyrosine kinase Tyk2-mediated phosphorylation of TIEG1 at Tyr179 promoted noncanonical K-27–linked polyubiquitination, which inhibited TIEG1 nuclear translocation. To test the role of TIEG1-regulated Treg/Th17 development in antitumor immunity, we analyzed TRAMP-C2 tumor growth in TIEG1−/− mice. The defective Treg development and elevated Th17 response resulted in enhanced immune reactivity in the tumor and inhibition of TRAMP-C2 tumor growth in TIEG1−/− mice. Thus, our results uncovered a novel regulatory mechanism that modulates Tregs and may regulate tumor progression.
CITATION STYLE
Peng, D.-J., Zeng, M., Muromoto, R., Matsuda, T., Shimoda, K., Subramaniam, M., … Venuprasad, K. (2011). Noncanonical K27-Linked Polyubiquitination of TIEG1 Regulates Foxp3 Expression and Tumor Growth. The Journal of Immunology, 186(10), 5638–5647. https://doi.org/10.4049/jimmunol.1003801
Mendeley helps you to discover research relevant for your work.